You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 152 No. 4, APRIL 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Increased Ventricular Response Rate During Exercise in Patients With Atrial Fibrillation Treated With Theophylline

Ginger L. Dattilo, MD; Charles E. Eiriksson, Jr, MD; Robert E. Vestal, MD

Arch Intern Med. 1992;152(4):797-803.


Abstract

The effect of theophylline on atrioventricular conduction in atrial fibrillation was investigated by determining ventricular response rates at rest and during exercise treadmill tests in eight patients (mean [±SEM] age, 64.2±2.0 years) with chronic atrial fibrillation. Tests were performed before and after 7 days of oral theophylline treatment (plasma level, 87.7±7.8 µmol/L). There was no significant change in baseline ventricular rate or duration of exercise, but the maximum ventricular rate with theophylline treatment was 12.3%±2.4% higher than that with placebo (176.3± ±7.5 vs 158.1 ±8.8 beats per minute), and, during each stage of exercise, the ventricular rate with theophylline exceeded that with placebo. The increased heart rate during theophylline administration occurred without a significant difference in the exercise-induced increase in circulating plasma catecholamine levels. We conclude that treatment with theophylline may contribute to difficulties with rate control in acutely ill patients with coexisting atrial fibrillation.

(Arch Intern Med. 1992;152:797-803)



Author Affiliations

From the Clinical Pharmacology and Gerontology Research Unit (Drs Dattilo and Vestal) and the Cardiology Section (Dr Eiriksson), Veterans Affairs Medical Center, Boise, Idaho; and Departments of Medicine (Drs Dattilo, Eiriksson, and Vestal) and Pharmacology (Dr Vestal), University of Washington, Seattle.


Footnotes

Accepted for publication September 27, 1991.

Reprint requests to Research Service (151), VA Medical Center, 500 W Fort St, Boise, ID 83702 (Dr Vestal).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.